Literature DB >> 11843137

Characterization of an iridovirus from the cultured pig frog Rana grylio with lethal syndrome.

Q Y Zhang1, F Xiao, Z Q Li, J F Gui, J Mao, V G Chinchar.   

Abstract

Three virus isolates, RGV-9506, RGV-9807 and RGV-9808, were obtained from cultured pig frogs Rana grylio undergoing lethal infections. Previously, the first isolate, RGV-9506, was shown to be an iridovirus based on ultrastructural and morphological studies. In the present study, the original isolate, along with 2 recent ones, were more extensively characterized by experimental infection studies, histopathology, electron microscopy, serological reactivity, gel electrophoresis of viral polypeptides and DNA restriction fragments, PCR amplification, and nucleic acid sequence analysis of the major capsid protein (MCP) gene. The 3 isolates were shown to be identical to each other, and very similar to FV3, the type species of the genus Ranavirus (family Iridoviridae). These results suggest that RGV should be considered a strain of FV3, and indicate that FV3-like iridoviruses are capable of causing widespread, severe disease among cultured frogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11843137     DOI: 10.3354/dao048027

Source DB:  PubMed          Journal:  Dis Aquat Organ        ISSN: 0177-5103            Impact factor:   1.802


  34 in total

1.  Broad distribution of Ranavirus in free-ranging Rana dybowskii in Heilongjiang, China.

Authors:  Kai Xu; Dong-Ze Zhu; Ying Wei; Lisa M Schloegel; Xiao-Feng Chen; Xiao-Long Wang
Journal:  Ecohealth       Date:  2010-03-09       Impact factor: 3.184

2.  Characterization of a PKR inhibitor from the pathogenic ranavirus, Ambystoma tigrinum virus, using a heterologous vaccinia virus system.

Authors:  Trung P Huynh; James K Jancovich; Latha Tripuraneni; Michael C Heck; Jeffrey O Langland; Bertram L Jacobs
Journal:  Virology       Date:  2017-09-14       Impact factor: 3.616

3.  Innate immune responses and permissiveness to ranavirus infection of peritoneal leukocytes in the frog Xenopus laevis.

Authors:  Heidi D Morales; Lara Abramowitz; Jacqueline Gertz; Jessica Sowa; Ashley Vogel; Jacques Robert
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

4.  Viral envelope protein 53R gene highly specific silencing and iridovirus resistance in fish Cells by AmiRNA.

Authors:  Yu-Sin Kim; Fei Ke; Xiao-Ying Lei; Rong Zhu; Qi-Ya Zhang
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

5.  Antibody dependent enhancement of frog virus 3 infection.

Authors:  Heather E Eaton; Emily Penny; Craig R Brunetti
Journal:  Virol J       Date:  2010-02-18       Impact factor: 4.099

6.  Complete genome sequence of lymphocystis disease virus isolated from China.

Authors:  Qi-Ya Zhang; Feng Xiao; Jian Xie; Zheng-Qiu Li; Jian-Fang Gui
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Strain variation in an emerging iridovirus of warm-water fishes.

Authors:  Tony L Goldberg; David A Coleman; Emily C Grant; Kate R Inendino; David P Philipp
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Phenotypic diversity of infectious red sea bream iridovirus isolates from cultured fish in Japan.

Authors:  Hajime Shinmoto; Ken Taniguchi; Takuya Ikawa; Kenji Kawai; Syun-ichirou Oshima
Journal:  Appl Environ Microbiol       Date:  2009-04-03       Impact factor: 4.792

9.  Mass mortality associated with a frog virus 3-like Ranavirus infection in farmed tadpoles Rana catesbeiana from Brazil.

Authors:  Rolando Mazzoni; Albenones José de Mesquita; Luiz Fernando F Fleury; Wilia Marta Elsner Diederichsen de Brito; Iolanda A Nunes; Jacques Robert; Heidi Morales; Alexandre Siqueira Guedes Coelho; Denise Leão Barthasson; Leonardo Galli; Marcia H B Catroxo
Journal:  Dis Aquat Organ       Date:  2009-11-09       Impact factor: 1.802

10.  Evidence for multiple recent host species shifts among the Ranaviruses (family Iridoviridae).

Authors:  James K Jancovich; Michel Bremont; Jeffrey W Touchman; Bertram L Jacobs
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.